Filtered By:
Condition: SARS

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 1917 results found since Jan 2013.

SARS-CoV2 infection in those on Mepolizumab therapy.
PMID: 33453381 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - January 13, 2021 Category: Allergy & Immunology Authors: Azim A, Pini L, Khakwani Z, Kumar S, Howarth P Tags: Ann Allergy Asthma Immunol Source Type: research

COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis.
This study was aimed to describe clinical manifestation and outcomes of MIS-C associated with COVID-19. This systematic review and meta-analysis were conducted on all available literature until July 3rd, 2020. The screening was done by using the following keywords: ("novel coronavirus" Or COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus) and ("MIS-C" or "multisystem inflammatory" or Kawasaki). Data on gender, ethnicity, clinical presentations, need for mechanical ventilation or admission to intensive care unit (ICU), imaging, cardiac complications, and COVID-19 laboratory results were...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 19, 2020 Category: Allergy & Immunology Authors: Baradaran A, Malek A, Moazzen N, Abbasi Shaye Z Tags: Iran J Allergy Asthma Immunol Source Type: research

Prevalence of SARS-CoV-2 in Patients with Severe Pneumonia in Khuzestan Province, Iran.
This study aimed to evaluate the frequency of SARS-CoV-2 in hospitalized patients with an acute respiratory infection (ARI). During an outbreak of the SARS-CoV-2, the nasopharyngeal and oropharyngeal swabs were collected from 909 hospitalized patients with severe pneumonia, including 517 (56.9%) males and 392 (43.1%) females. All the collected samples were from different cities of Khuzestan province from 19 February to- 27 March 2020. The RNA was extracted from samples and subjected to real-time polymerase chain reaction (PCR) tests for the detection of the SARS-CoV-2. Simultaneously, the computerized tomography (CT) scan ...
Source: Iranian Journal of Allergy, Asthma and Immunology - October 18, 2020 Category: Allergy & Immunology Authors: Abolnezhadian F, Makvandi M, Alavi SM, Azaran A, Jalilian S, Rashno M, Kaydani GA, Arshadi M, Hosseinizadeh SM, Boostani H, Seyedian SS, Moogahi S, Salmanzadeh S, Varnaseri M, Neisi N, Keifarrokhi H, Shariati G, Amiri H, Parsanahad M, Nashibi R, Yousefi F Tags: Iran J Allergy Asthma Immunol Source Type: research

Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
Abstract The new coronavirus, known as "SARS-CoV-2"; is the cause of one of the most prevalent infectious viral diseases that was recently announced pandemic by the world health organization. Ongoing research in the fields of prevention, management, and therapy establishes a functional scaffold for clinics during the time of crisis. To obtain this goal, it is necessary that all pathophysiologic aspects of COVID-19 from infection to predisposing backgrounds of infection be identified, so that all the ambiguities of researchers regarding transmission mechanisms, variable clinical manifestation, and therapeutic respo...
Source: Iranian Journal of Allergy, Asthma and Immunology - October 18, 2020 Category: Allergy & Immunology Authors: Imani-Saber Z, Vaseghi H, Mahdian M, Safari F, Ghadami M Tags: Iran J Allergy Asthma Immunol Source Type: research

An Institutional Survey of Patient Satisfaction with Telemedicine Services in Pediatric Allergy During the COVID-19 Pandemic
This study investigates parent satisfaction with telemedicine services offered at a pediatric allergy clinic during the SARS-CoV2 pandemic.
Source: Journal of Allergy and Clinical Immunology - February 1, 2021 Category: Allergy & Immunology Authors: Kasey Lanier, Merin Kuruvilla, Jennifer Shih Source Type: research

Clinical Characteristics of SARS-CoV2 Infected and Exposed Patients at a Tertiary Care Allergy/Immunology Program in Florida
Immunocompromised persons are logically thought to have increased risk of severe SARS-CoV-2 infection (COVID-19) and Florida has one of the highest number of COVID-19 cases nationally. How allergic and immunologic disorders affect the clinical course of COVID-19 is not fully understood. Hence, we characterized the demographics, symptoms, diagnosis, comorbidities, and disease severity of patients in our academic allergy/immunology program in Florida with SARS-CoV2 infection or direct exposure to household contacts.
Source: Journal of Allergy and Clinical Immunology - February 1, 2021 Category: Allergy & Immunology Authors: Mary Ann Miranda, Joseph Dasso, Maryssa Ellison, Jessica Trotter, Priyanka Timothy, Maria Chitty-Lopez, Carla Duff, Daime Nieves, Emma Westermann-Clark, Nathan Tang, Mandel Sher, Mark Ballow, Jennifer Leiding, Panida Sriaroon, Jolan Walter Source Type: research

COVID Fatigue in the Allergy Clinic
In January 2020 the world became aware of a novel virus circulating in Wuhan, China. By March 2020 SARS-CoV-2, had spread across the globe prompting a pandemic declaration by the World Health Organization and “shutdowns” of varying degrees in almost every facet of life.1 The healthcare industry was certainly not spared. Many in the specialty of Allergy& Immunology saw their practices adversely affected as patients were afraid to venture into clinical settings. Allergists were forced to modify their approach to patient care as they were unsure how to keep their patients and staff safe.
Source: Annals of Allergy, Asthma and Immunology - March 31, 2021 Category: Allergy & Immunology Authors: Joseph P. Forester, Sumana C. Reddy, J. Wesley Sublett, Marissa R. Shams, J. Allen Meadows Source Type: research

Coronavirus disease 2019 fatigue in the allergy clinic
In January 2020, the world became aware of a novel virus circulating in Wuhan, China. By March 2020, severe acute respiratory syndrome coronavirus 2 had spread across the globe prompting a pandemic declaration by the World Health Organization and shutdowns of varying degrees in almost every facet of life.1 The health care industry was certainly not spared. Many in the specialty of allergy and immunology saw their practices adversely affected because patients were afraid to venture into clinical settings.
Source: Annals of Allergy, Asthma and Immunology - March 31, 2021 Category: Allergy & Immunology Authors: Joseph P. Forester, Sumana C. Reddy, J. Wesley Sublett, Marissa R. Shams, J. Allen Meadows Tags: Perspective Source Type: research

Influenza vaccination patterns in an Allergy specialty clinic during COVID-19
We sought to determine the effect of the SARS-COV-2 pandemic on seasonal influenza vaccine patterns in a tertiary care, pediatric Allergy clinic.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Jackson Massanelli, Robbie Pesek, Amika Sood, Kim Cobb, Stacie Jones Source Type: research

A novel allergist-integrative model for vaccine allergy safety
The World Health Organization declared coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after its initial emergence in Wuhan, China, in December 2019 and its global spread, a pandemic, on March 11, 2020. Vaccination remains the most promising strategy to end the COVID-19 pandemic. Many different public organizations and private companies worked together to make COVID-19 vaccines made available to the public. Given the novel nature of messenger RNA vaccines and initial global concerns over vaccine-related allergic reactions, worldwide health authorities took a co...
Source: Annals of Allergy, Asthma and Immunology - August 19, 2022 Category: Allergy & Immunology Authors: Ruby Pawankar, Bernard Yu-Hor Thong Tags: Editorial Source Type: research

Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract
Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507 | DOI:10.23822/EurAnnACI.1764-1489.275
Source: European Annals of Allergy and Clinical Immunology - December 2, 2022 Category: Allergy & Immunology Authors: A Gaspar A L Moura C Cruz L M Borrego Source Type: research